ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 638199 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 638199; 2) Community: the network communities that were significantly associated with the response to NSC 638199; 3) Molecule: the relationships between components within communities and NSC 638199; 4) MDR: the compounds that were significantly associated with the NSC 638199.

NSC Compound Enrichment Correlation
NSC 748643 Mitaplatin 0.049093561024907 0.38021537
NSC 748742 Null 0.049093561024907 -0.25944085
NSC 753188 4-chloro-N-(4-(3-(4-chloro-3-hydroxyphenyl)-4-(pyridin-4-yl)-1H-pyrazol-1-yl)phenyl)-3-(trifluoromethyl)benzamide 0.049093561024907 0.34791482
NSC 753664 Null 0.049093561024907 0.44683707
NSC 79037 Lomustine 0.049093561024907 0.52655228
NSC 88916 10,13-dimethyl-17-(2-methyl-1,3-thiazol-4-yl)-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one 0.049093561024907 0.3977933
NSC 93674 Oxyacanthan-7,12'-diol, 6,6'-dimethoxy-2,2'-dimethyl- 0.049093561024907 0.4076336
NSC 86371 Quinolinium, 2-[2-(8-hydroxy-5-methyl-7-quinolyl)vinyl]-1,6-dimethyl- iodide 2.60114781708976e-005 0.35549059
NSC 321237 Mercury, (4-aminophenyl)(6-thioguanosinato-N7,S6)- 3.40252996142932e-005 0.46856398
NSC 618939 Camptothecin Derivative 3.40252996142932e-005 0.47420344
Total:109  Current:108    [First] [Prev] [Next] [Last]